TMX Newsfile

IN THE PRESS

Press Releases

Restart Life Closes Over-Subscribed Second Tranche Financing

December 18, 2025

·

2 min read

Press Releases

Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

December 18, 2025

·

7 min read

Press Releases

BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform

December 18, 2025

·

3 min read

Press Releases

TempraMed Expands U.S. Manufacturing Capacity with New Production Facility in Florida

December 17, 2025

·

5 min read

Press Releases

NervGen Pharma Announces Filing of Form F-10 Registration Statement with The SEC Under MJDS

December 17, 2025

·

5 min read

Press Releases

Restart Life Announces Food Technology and Research Studies

December 17, 2025

·

6 min read

Press Releases

BioVaxys Announces Positive Phase 1 Clinical Study Results with Maveropepimut-S (MVP-S) in Women with Hormone Receptor Positive/HER2 Negative (HR+/HER2-) Stage II-III Breast Cancer

December 17, 2025

·

9 min read

Press Releases

Mayo Clinic Jacksonville Comes Online as Third Site in Breathe BioMedical’s Ongoing Multi-Center Clinical Study to Develop a Breath Test for Early Detection of Breast Cancer in Females with Dense Breasts

December 16, 2025

·

3 min read

Press Releases

Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio

December 16, 2025

·

9 min read

Press Releases

OS Therapies Announces Successful Type C Meeting with US FDA Regarding Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma

December 15, 2025

·

9 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750